Novo Nordisk A/S (CPH: NOVO.B)

Novo Nordisk Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,606,810	3,112,331	2,118,803	1,674,992	986,612	909,347
Market Cap Growth	21.09%	46.89%	26.50%	69.77%	8.50%	27.49%
Enterprise Value	2,588,901	3,091,273	2,107,299	1,653,350	965,236	894,933
Last Close Price	589.20	690.44	458.03	353.60	201.34	178.54
PE Ratio	27.79	37.19	38.16	35.07	23.41	23.35
Forward PE	22.42	32.62	40.03	34.03	21.33	21.14
PS Ratio	9.71	13.40	11.97	11.90	7.77	7.45
PB Ratio	21.77	29.21	25.38	23.68	15.58	15.79
P/TBV Ratio	52.81	67.43	65.10	60.74	23.12	17.57
P/FCF Ratio	33.53	37.45	31.75	34.42	21.39	24.03
P/OCF Ratio	29.50	28.58	26.86	30.45	18.99	19.44
PEG Ratio	1.11	1.74	2.45	3.07	2.31	2.58
EV/Sales Ratio	9.57	13.31	11.91	11.74	7.60	7.33
EV/EBITDA Ratio	19.26	28.15	26.06	25.93	16.48	15.89
EV/EBIT Ratio	20.62	29.73	27.89	27.92	17.83	17.05
EV/FCF Ratio	33.30	37.20	31.57	33.97	20.93	23.64
Debt / Equity Ratio	0.47	0.25	0.31	0.38	0.16	0.08
Debt / EBITDA Ratio	0.42	0.24	0.31	0.41	0.17	0.08
Debt / FCF Ratio	0.73	0.32	0.39	0.55	0.22	0.12
Asset Turnover	0.78	0.84	0.81	0.83	0.94	1.03
Inventory Turnover	1.23	1.27	1.29	1.24	1.16	1.18
Quick Ratio	0.74	0.62	0.67	0.65	0.64	0.76
Current Ratio	0.94	0.82	0.89	0.86	0.94	1.06
Return on Equity (ROE)	88.73%	88.07%	72.00%	71.24%	69.70%	71.19%
Return on Assets (ROA)	22.49%	23.39%	21.68%	21.81%	25.01%	27.75%
Return on Capital (ROIC)	52.81%	53.53%	45.71%	43.27%	49.84%	57.33%
Earnings Yield	3.60%	2.69%	2.62%	2.85%	4.27%	4.28%
FCF Yield	2.98%	2.67%	3.15%	2.91%	4.68%	4.16%
Dividend Yield	1.68%	1.36%	1.35%	1.47%	2.26%	2.34%
Payout Ratio	46.60%	37.96%	45.57%	45.06%	47.75%	49.83%
Buyback Yield / Dilution	0.86%	1.10%	1.34%	1.58%	1.63%	1.89%
Total Shareholder Return	2.54%	2.46%	2.69%	3.05%	3.89%	4.22%

Source: S&P Capital IQ. Standard template. Financial Sources.